Peptide Dictionary (75)

A PTHrP analog that stimulates bone formation with potentially less hypercalcemia risk than teriparatide.

Alpha-MSH analog stimulating melanogenesis for erythropoietic protoporphyria

Synthetic angiotensin II used as a vasopressor for refractory vasodilatory shock.

A modified fragment of human growth hormone studied for its fat-reducing properties.

An oxytocin receptor antagonist used to delay imminent preterm delivery.

A direct thrombin inhibitor used for anticoagulation during cardiac catheterization procedures.

First-in-class reversible proteasome inhibitor for multiple myeloma

A gastric pentadecapeptide researched for tissue-healing and anti-inflammatory properties.

Fixed-dose combination of semaglutide and cagrilintide (amylin analog)

A salmon-derived calcitonin peptide that inhibits bone resorption and provides analgesic effects.

An irreversible proteasome inhibitor for relapsed or refractory multiple myeloma.

A synthetic GHRH analog that stimulates sustained growth hormone release from the pituitary.

GnRH antagonist with immediate testosterone suppression without flare

A synthetic vasopressin analog for diabetes insipidus, bedwetting, and bleeding disorders.

A peripheral kappa opioid receptor agonist for treatment of chronic itch in dialysis patients.

Delta Sleep-Inducing Peptide, a neuromodulator studied for sleep promotion and stress adaptation.

A once-weekly GLP-1 receptor agonist with Fc fusion for sustained diabetes management.

A mitochondria-targeted tetrapeptide being developed for Barth syndrome and mitochondrial diseases.

The first-in-class HIV fusion inhibitor that blocks viral entry into host cells.

A synthetic tetrapeptide studied for its ability to activate telomerase and regulate cellular aging.

Cyclic peptide GPIIb/IIIa inhibitor preventing platelet aggregation

An IV calcimimetic peptide for secondary hyperparathyroidism in hemodialysis patients.

A GLP-1 receptor agonist derived from Gila monster venom for type 2 diabetes treatment.

A copper-binding tripeptide naturally found in human plasma, studied for skin regeneration and anti-aging.

A synthetic hexapeptide GH secretagogue approved in Japan for diagnosis of GH deficiency.

A synthetic hexapeptide that potently stimulates growth hormone secretion via the ghrelin receptor.

A pancreatic hormone used as an emergency treatment for severe low blood sugar and as a diagnostic aid.

A synthetic GnRH (gonadotropin-releasing hormone) used to stimulate or test pituitary LH/FSH release.

GnRH superagonist implant for hormone-dependent cancers

A synthetic hexapeptide GH secretagogue with unique cardioprotective properties independent of GH release.

Bradykinin B2 receptor antagonist for acute HAE attacks

Novel oral anti-diabetic targeting mitochondrial bioenergetics

A selective growth hormone secretagogue that stimulates GH release without affecting cortisol or prolactin.

A neuropeptide that plays a central role in regulating reproductive hormone release and puberty onset.

A C-terminal tripeptide of alpha-MSH with potent anti-inflammatory and antimicrobial properties.

Long-acting somatostatin analog with deep SC depot formulation

A tight junction modulator being developed as an adjunctive therapy for celiac disease.

A GnRH superagonist that suppresses sex hormone production for cancer and reproductive conditions.

A guanylate cyclase-C agonist for irritable bowel syndrome with constipation and chronic constipation.

A once-daily GLP-1 receptor agonist for type 2 diabetes and chronic weight management.

A once-daily GLP-1 receptor agonist for glycemic control in type 2 diabetes.

The only human cathelicidin antimicrobial peptide, involved in innate immune defense and wound healing.

A synthetic melanocortin peptide that stimulates melanin production and has been studied for tanning effects.

A mitochondria-derived peptide that regulates metabolic homeostasis and has exercise-mimetic properties.

An intranasal GnRH agonist used for endometriosis and central precocious puberty.

Recombinant BNP for acute decompensated heart failure

A synthetic somatostatin analog used to treat acromegaly, carcinoid syndrome, and neuroendocrine tumors.

Non-peptide oral GLP-1 receptor agonist with small-molecule-like properties

An endogenous neuropeptide hormone used clinically for labor induction and control of postpartum bleeding.

Multi-receptor somatostatin analog with high SSTR5 affinity

GLP-1/glucagon dual agonist optimized for liver fat reduction

A uroguanylin analog that treats constipation by stimulating intestinal fluid secretion.

Synthetic amylin analog slowing gastric emptying and reducing postprandial glucose

A melanocortin receptor agonist approved for hypoactive sexual desire disorder in women.

Triple incretin agonist targeting GLP-1/GIP/glucagon receptors

Hepcidin mimetic peptide reducing iron-driven erythrocytosis

A synthetic peptide derived from tuftsin, developed as an anxiolytic and nootropic agent.

A GLP-1 receptor agonist used for type 2 diabetes and chronic weight management.

A synthetic analog of ACTH(4-10) developed as a nootropic and neuroprotective agent.

A GHRH analog that stimulates the pituitary to release growth hormone naturally.

An MC4R agonist approved for obesity caused by specific genetic deficiencies in the melanocortin pathway.

An endogenous undecapeptide neurotransmitter central to pain signaling and neurogenic inflammation.

Dual glucagon/GLP-1 receptor agonist for obesity and metabolic liver disease

A synthetic fragment of Thymosin Beta-4 studied for tissue repair and anti-inflammatory effects.

GLP-2 analog promoting intestinal mucosal growth and nutrient absorption

A recombinant PTH fragment that stimulates new bone formation for severe osteoporosis treatment.

An FDA-approved GHRH analog used to reduce excess abdominal fat in HIV-associated lipodystrophy.

An immunomodulatory peptide used to enhance immune function in chronic infections.

A naturally occurring 43-amino acid peptide involved in tissue repair and cell migration.

A first-in-class dual GIP/GLP-1 receptor agonist for diabetes and weight management.

A GnRH superagonist with depot formulations for treatment of hormone-dependent conditions.

An endogenous posterior pituitary hormone used as a vasopressor in critical care settings.

An endogenous 28-amino acid neuropeptide with broad vasodilatory, immunomodulatory, and neuroprotective properties.

A synthetic cone snail venom peptide for severe chronic pain refractory to other treatments.

Macrocyclic peptide complement C5 inhibitor for myasthenia gravis